NeuroOne Medical Technologies Corporation Common Stock NMTC
$1.83
+20.39%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $7.60
- Implied Upside
- +315.3%
- Price Target Range
- $5.00 – $9.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $13 → $5 |
| 2026-05-13 | Ladenburg ThalmannJeff Cohen |
Maintains | Buy | $2 → $9 |
| 2026-03-02 | Jones TradingJustin Walsh |
Initiates coverage on | Buy | $9 |
| 2025-09-09 | Maxim GroupAnthony Vendetti |
Initiates coverage on | Buy | $3 |
| 2025-05-05 | Ladenburg ThalmannJeff Cohen |
Initiates coverage on | Buy | $1 |
| 2023-08-15 | Alliance Global PartnersBen Haynor |
Maintains | Buy | $3 → $2 |
| 2022-03-28 | Craig-HallumAlexander Nowak |
Downgrades | Buy → Hold | — |
| 2021-12-03 | Alliance Global Partners |
Initiates coverage on | Buy | $6 |
| 2021-11-15 | Craig-HallumAlexander Nowak |
Initiates coverage on | Buy | $6 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $1.83
- Market Cap
- $13.23 million
- 52-Week Range
- $1.42 – $6.96
- Average Volume
- 66K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.